/
National Lynch Syndrome project National Lynch Syndrome project

National Lynch Syndrome project - PowerPoint Presentation

summer
summer . @summer
Follow
68 views
Uploaded On 2023-07-19

National Lynch Syndrome project - PPT Presentation

Sarah John and Siobhan John SW Nurse facilitators Why worry about Lynch Each year 1100 colorectal cancers are caused by Lynch syndrome making it the most common form of hereditary colorectal cancer ID: 1009511

syndrome lynch colorectal cancer lynch syndrome cancer colorectal 100 immunotherapy ensure trusts cancers options test patients john treatment audit

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "National Lynch Syndrome project" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. National Lynch Syndrome projectSarah John and Siobhan John SW Nurse facilitators

2. Why worry about Lynch?Each year, 1,100 colorectal cancers are caused by Lynch syndrome, making it the most common form of hereditary colorectal cancer. An estimated 175,000 people have Lynch syndrome in the UK, but fewer than 5% of individuals know they have the condition (Bowel Cancer UK).

3. When should we test?A dMMR can affect cancer treatment options, certain tumours are more responsive to particular chemotherapy agents as well as new immunotherapy drugs called check point inhibitors. It is therefore important that the initial tumour test is done in time to inform treatment options

4. Immunotherapy in Lynch Syndrome

5. Improving diagnostic pathways

6. Example of completed baseline audit

7. Analysis of AuditsTrust ATrust BIHC/MSI97 %95%Colon biopsies39%9%Methylation/BRAF100%100%Discussion at MDT75%0%Referral Genetics60%NA

8. Our RoleTo support trusts across to the south west to ensure patients with colorectal and endometrial cancers are routinely tested for lynch at diagnosis.To ensure patients are on the correct surveillance pathway and they are added to the regional database.Doing this Through supporting trusts to audit their current provision and highlighting good and bad practiceImplementing mainstream germline testing